These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 33295221)

  • 1. Anosmia: A Clinical Indicator of COVID-19 Reinfection.
    Jain A; Kaur J; Rai AK; Pandey AK
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):180S-181S. PubMed ID: 33295221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 with and without anosmia or dysgeusia: A case-control study.
    Dev N; Sankar J; Gupta N; Meena RC; Singh C; Gupta DK; Sen MK
    J Med Virol; 2021 Apr; 93(4):2499-2504. PubMed ID: 33417259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.
    Zayet S; Klopfenstein T; Mercier J; Kadiane-Oussou NJ; Lan Cheong Wah L; Royer PY; Toko L; Gendrin V
    Infection; 2021 Apr; 49(2):361-365. PubMed ID: 32410112
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19, cilia, and smell.
    Li W; Li M; Ou G
    FEBS J; 2020 Sep; 287(17):3672-3676. PubMed ID: 32692465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of smell and taste in COVID-19 infection in adolescents.
    Kumar L; Kahlon N; Jain A; Kaur J; Singh M; Pandey AK
    Int J Pediatr Otorhinolaryngol; 2021 Mar; 142():110626. PubMed ID: 33477014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis.
    Purja S; Shin H; Lee JY; Kim E
    Arch Pharm Res; 2021 Jul; 44(7):725-740. PubMed ID: 34302637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Taste Loss in a COVID-19 Patient With Preexisting Chronic Smell Impairment.
    Klein H; Karni N; Israel S; Gross M; Muszkat M; Niv MY
    J Investig Med High Impact Case Rep; 2021; 9():2324709621990765. PubMed ID: 33535814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 and dengue: two case reports.
    Hilmy AI; Dey RK; Imad HA; Yoosuf AA; Nazeem A; Latheef AA
    J Med Case Rep; 2021 Mar; 15(1):171. PubMed ID: 33771221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.
    Krishnakumar HN; Momtaz DA; Sherwani A; Mhapankar A; Gonuguntla RK; Maleki A; Abbas A; Ghali AN; Al Afif A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):505-509. PubMed ID: 36209486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients.
    Shahrvini B; Prajapati DP; Said M; Liu J; Srinivas S; Jayaraj S; Lund VJ; DeConde AS; Lechner M; Yan CH
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1280-1282. PubMed ID: 33864717
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review.
    Samaranayake LP; Fakhruddin KS; Panduwawala C
    Acta Odontol Scand; 2020 Aug; 78(6):467-473. PubMed ID: 32762282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Students' Awareness of Smell Loss as a Predictor for Coronavirus Disease 2019.
    Aldrees T; Almatrafi S; Aldriweesh T; Mokhatrish M; Salamh A; Alkholaiwi F
    Front Public Health; 2020; 8():597897. PubMed ID: 33363090
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19.
    Burges Watson DL; Campbell M; Hopkins C; Smith B; Kelly C; Deary V
    PLoS One; 2021; 16(9):e0256998. PubMed ID: 34559820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.
    Trachootham D; Thongyen S; Lam-Ubol A; Chotechuang N; Pongpirul W; Prasithsirikul W
    Int J Infect Dis; 2021 May; 106():329-337. PubMed ID: 33819604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taste and Smell Impairment in Critically Ill Patients With COVID-19: An Intensive Care Unit Study.
    Sayın P; Altınay M; Cınar AS; Ozdemir HM
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):174S-179S. PubMed ID: 33258690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study.
    Barillari MR; Bastiani L; Lechien JR; Mannelli G; Molteni G; Cantarella G; Coppola N; Costa G; Trecca EMC; Grillo C; La Mantia I; Chiesa-Estomba CM; Vicini C; Saussez S; Nacci A; Cammaroto G
    J Med Virol; 2021 Feb; 93(2):983-994. PubMed ID: 32710639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
    Song KH; Kim DM; Lee H; Ham SY; Oh SM; Jeong H; Jung J; Kang CK; Park JY; Kang YM; Kim JY; Park JS; Park KU; Kim ES; Kim HB
    Korean J Intern Med; 2021 Jan; 36(1):11-14. PubMed ID: 32972123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.